Uwe Platzbecker

39.4k citations
551 papers · 11.7k · 2 hit papers · h-index 55

Impact in

  • Hematology top 0.02%
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
    • Chronic Myeloid Leukemia Treatments
  • Genetics top 0.05%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment
    • Hemoglobinopathies and Related Disorders
    • Chronic Lymphocytic Leukemia Research

Papers in

    • Acute Myeloid Leukemia Research 341
    • Hematopoietic Stem Cell Transplantation 96
    • Chronic Myeloid Leukemia Treatments 69
    • Multiple Myeloma Research and Treatments 48
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 116
    • Hemoglobinopathies and Related Disorders 61
    • Chronic Lymphocytic Leukemia Research 47

Uwe Platzbecker

516 papers receiving 11.5k citations

Uwe Platzbecker's Hit Papers

Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate- or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group 2011 · 408 citations
4080+8+16Years since publication4008001.2k

Peers

Uwe Platzbecker
Comparison fields: 5 of 128
  • Hematology 8.5k
  • Genetics 3.6k
  • Immunology 1.3k
  • Oncology 1.5k
  • Transplantation 145
Replace Nigel H. Russell with:
Nigel H. Russell United Kingdom
Norbert Ifrah France
Ulrich Germing Germany
Jordi Esteve Spain
Sherry Pierce United States
Azra Raza United States
Hervé Dombret France
Alessandra Ferrajoli United States
Joan Bladé Spain
Sundar Jagannath United States
Uwe Platzbecker relative to Nigel H. Russell United Kingdom Nigel H. Russell's profile →
Citations per field
00.5×2.9×
Nigel H. Russell · 1×
Citations per year

Countries citing papers authored by Uwe Platzbecker

Since Specialization
Citations

This map shows the geographic impact of Uwe Platzbecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uwe Platzbecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uwe Platzbecker more than expected).

Fields of papers citing papers by Uwe Platzbecker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uwe Platzbecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uwe Platzbecker. The network helps show where Uwe Platzbecker may publish in the future.

Co-authors

The 25 scholars most cited alongside Uwe Platzbecker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Uwe Platzbecker Line = papers co-authored together Uwe Platzbecker links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 551 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis
Hit paper breakdown →
20021277
2
Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate- or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group
Hit paper breakdown →
2011408
3 2011296
4 2004242
5 2008233
6 2017220
7 2017212
8 2013185
9 2011172
10 2016169
11 2013168
12 2015140
13 2013140
14 2019140
15 2010120
16 2014119
17 2012105
18 2020105
19 2011104
20 2018104

About Uwe Platzbecker

Uwe Platzbecker is a scholar working on Hematology, Genetics, Molecular Biology, Oncology and Public Health, Environmental and Occupational Health, having authored 551 papers that have together received 11.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (341 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (116 papers), Hematopoietic Stem Cell Transplantation (96 papers), Chronic Myeloid Leukemia Treatments (69 papers), Hemoglobinopathies and Related Disorders (61 papers), Acute Lymphoblastic Leukemia research (59 papers), Multiple Myeloma Research and Treatments (48 papers) and Chronic Lymphocytic Leukemia Research (47 papers). The work is most often cited by research in Hematology (8.5k citations), Genetics (3.6k citations), Immunology (1.3k citations), Oncology (1.5k citations) and Transplantation (145 citations). Uwe Platzbecker has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Martin Bornhäuser, Gerhard Ehninger, Christian Thiede, Markus Schaich, Thomas Illmer, Pierre Fenaux, Brigitte Mohr, Martin Wermke, Aristoteles Giagounidis and Andreas Neubauer. Their work appears in journals such as Blood, Leukemia, Journal of Clinical Oncology, Leukemia Research and Annals of Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact